Bioceros offers cell line generation services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines. BGV sold its stake in a management buyout in 2011.
Member count: 11-50
Investors 1
| Date | Name | Website |
| 03.08.2021 | BioGenerat... | biogenerat... |